https://www.selleckchem.com/pr....oducts/diphenyleneio
Transcranial direct-current stimulation (tDCS) has shown promise to decrease fatigue. However, it has never been examined in primary Sjogren Syndrome (pSS). To assess the effect of a tDCS protocol on fatigue in patients with pSS. This is a parallel, double-blind pilot study (NCT04119128). Women aged 18-65 years, with pSS, on stable pharmacological therapy, with complaints of fatigue for at least three months, and with scores 5 on Fatigue Severity Scale (FSS) were included. We randomized 36 participants to re
Like
Comment
Share
